Trial intelligence / Profile preview

C1-esterase inhibitor during human endotoxemia

NL-OMON32783Not yet recruiting

Sponsor
Radboud University Medical Center
Start
Sep 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised trial of c1-esterase inhibitor in chronic inflammation and sepsis (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Circulating cytokine and C-reactive protein concentrations. Planned start Sep 2008; status: not yet recruiting.

02

Drugs

c1-esterase inhibitor
03

Conditions

chronic inflammationsepsis

Beyond the preview

Go deeper on NL-OMON32783.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON32783.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call